Omnicell to Present at Stifel Nicolaus Healthcare Conference 2011
MOUNTAIN VIEW, Calif., Aug. 31, 2011 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at the Stifel Nicolaus 2011 Healthcare Conference at the Four Seasons Hotel, Boston, MA.
Omnicell Speakers: Randall A. Lipps, founder, chairman, president & CEO and Rob Seim, vice president & CFO
Date: Wednesday, September 7, 2011
Time: 9:45 a.m. ET
Location: Four Seasons Hotel, Boston, MA Stuart Room
Availability: The audio-webcast of the live presentation may be accessed by visiting: http://www.veracast.com/webcasts/stifel/healthcare2011/13104388.cfm
Following the conference, a replay of the audio-webcast will be archived for 30 days on the Omnicell website.
About Omnicell
Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of automated and business information solutions enabling hospitals and healthcare systems to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. Through seamless integration with a hospital's existing IT infrastructure, Omnicell solutions empower healthcare facilities to achieve comprehensive automation of medication and supply management from the arrival at the loading dock to the patient's bedside. Omnicell also provides healthcare facilities with business analytics software designed to improve medication diversion detection and regulatory compliance.
Since 1992, more than 2,200 hospital customers worldwide have relied on Omnicell's medication automation, supply chain, and hospital analytics solutions to increase patient safety, improve efficiency and address changing healthcare regulations while providing effective control of costs, charge capture for payer reimbursement and inventory management of medications and supplies.
For more information about Omnicell, please visit www.omnicell.com.
OMCL-E
SOURCE Omnicell, Inc.